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ABSTRACT
A DETAILED PARAMETER STUDY INTO THE DERMAL ABSORPTION OF
CHEMICAL WARFARE AGENTS AND THE EFFECTS OF
PHARMACOKINETICS

by
Koko Lear
Chemical warfare agents (CWAs) are substances of varying toxicity profiles. These
chemicals exhibit complex dynamics and pose a serious health risk when released into the
environment. A mathematical model based on Fick’s second law of diffusion was
developed to comprehend how these compounds were absorbed into the skin. The analysis
applied to both small and large doses and, successfully, predicted experimental results.
This work also includes the effects of CWA physicochemical properties on evaporation
and dermal absorption through the stratum corneum. A sensitivity analysis was conducted
to assess the impacts of small variations in the initial dose, environmental conditions, and
key model parameters (e.g., diffusion coefficient) on the permeation kinetics. In addition,
a concept-based assessment about the roles of skin metabolism and binding is also
presented. Our results show that the diffusion coefficient, the ratio of the steady-state
evaporation rate to the steady-state absorption rate, and the initial dose impact the
cumulative amount of permeant absorbed or evaporated.
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CHAPTER 1
INTRODUCTION
1.1 Brief Background on Chemical Warfare Agents
Chemical warfare is defined as the use of toxicity of chemical compounds to kill, injure,
or incapacitate an enemy in warfare and associated military operations (Chauhan et al.,
2008). Chemical warfare agents (CWAs) have historically been used since ancient times
with the usage of poisoned arrows and other crude chemicals in various weapon
apparatuses (Black, 2016). Another instance of ancient usage dates back to 600 B.C. where
the biological warfare agent, Helleborus root, was used to contaminate the water supplies
in the siege of Kirrha (Chauhan et al., 2008). The usage of chemicals as a means to either
combat against foes in defensive or offensive maneuvers has thus been long acknowledged
as a key tactical advantage.
As time passed, designs for the release of chemicals have become more
sophisticated than the previous iterations. However, the most explosive time period for
CWAs has been the twentieth century as it has seen the full capabilities of CWAs in a
world war, a regional conflict, and the first instance of their use by terrorists (Coleman,
2005). WWI marked an important turning point for the culture of the battlefield and the
views and capabilities of CWAs. Between Germany, France, Britain, the US, Austria, Italy,
and Russia, it is reported that forty-six different gases were created and used in the war
leading to the famous nickname for WWI being “The Chemists’ War” (Freemantle, 2015).
The tumultuous start of a mass scale usage of CWAs can be attributed to the German
designer, Fritz Haber. Haber’s creation of Germany’s poison-gas weapon system started as
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a response to trench warfare. Due to his work in the field of weaponized chemicals, he is
now regarded as the father of modern chemical warfare (Freemantle, 2015). As a result of
Haber making chemical weapons better-known from his WWI involvement, many
countries soon adopted and employed similar tactics.
As such, a surge in manufacturing and delivery systems has arisen across the globe
for countries to match defense systems against other nations. With this climate change,
tensions have stirred for how best to contain and handle CWAs during storage and
stockpiling and how to mitigate the effects of exposure. A multilateral treaty stated that
every ten years CWA stockpiles much be destroyed (Chauhan et al., 2008). This legislation,
enacted from the chemical weapons convention, was created to regulate better and contain
CWAs to minimize harm.
Presently, methods to counteract the spread of the effects caused by exposure to
various CWAs have been a growing research topic. However, choosing one simulant to
represent all those CWAs is difficult because of their numerous innate properties. As a
result, multiple simulants need to be chosen (Cao et al., 2020). A classification system was
created to group compounds of similar properties to treat exposed victims better. CWAs
are defined as one of eight different classes: nerve agents, vesicants (also known as
blistering agents), blood agents, lung injurants, riot-control agents, psychotomimetic
agents, toxins, and vomiting agents (K Ganesan et al., 2010). Nerve agents target the body’s
nervous system with typical entrance routes of either inhalation or dermal contact (Wexler
& Anderson, 2014). Vesicants are defined as compounds that create severe chemical burns
that may result in painful blisters and lesions to the skin (Hilmas & Hilmas, 2009). This
class of CWAs is said to enter through inhalation, dermal, or ocular routes (Goswami et
2

al., 2018). Blood agents enter the bloodstream, typically, by inhalation or ingestion, with
nausea and dizziness being the early signs of exposure. Lung injurants, also commonly
called choking agents, compromise the respiratory tract, leading to victims losing breath
and choking (K. Ganesan et al., 2010). Riot-control agents are the most commonly used
CWA in times of war. They are applied to temporarily disarm a person when the compound
contacts the eyes, skin, or is inhaled (Wexler & Anderson, 2005). As such, these agents are
typically deployed for use as crowd control. Psychomimetic agents create hallucinations
and are meant to incapacitate an individual by harming the central nervous system (K.
Ganesan et al., 2010). Toxins are biological substances that are found in nature. They have
poisonous or toxic effects (Janik et al., 2019).
Physical or chemical decontamination is usually the primary initial response to
treating dermal exposure. Defining a chemical’s properties increases the efficacy of
decontamination to the skin’s surface and back-extract chemicals from the stratum
corneum’s reservoir to reduce the penetration and systemic absorption of the compound
(Cao et al., 2020). Research for assisting decontamination methods for chemical weapons
has focused on parameter studies' importance to help create mathematical models. Current
methodologies to estimate the rate of dermal absorption are based on Fick’s second law,
which was proven to predict and model transport through the skin successfully (Kasting &
Miller, 2006). Therefore, an application utilizing computational programming can help
improve risk assessment and estimate the time window to respond to chemical exposure.
1.2 Literature Review
The skin is a crucial organ to study when considering how compounds can freely interact
with it. As the largest and most complex organ of the human body (Mueller, 2017), the
3

skin is comprised of various protective layers and mechanical barriers like hair follicles
(Gorzelanny et al., 2020), which serve as protection from the environment. The stratum
corneum (SC) is the outermost layer of the skin and thus the first barrier that guards against
external threats. The stratum corneum is regarded as the major barrier for most permeants
and, as such, is the focus of many steady-state and transient models (Dancik et al.). This
layer has a rate-limiting mechanism for transdermal uptake as it delays penetration into the
viable epidermis and below (Gorzelanny et al., 2020).
Another important aspect of dermal investigation lies in the skin layer's thickness.
The hydration of the skin layer varies significantly from person to person. The stratum
corneum is estimated to be 10 – 15 μm thick (Andrews et al., 2013). A partially hydrated
stratum corneum differs from a fully hydrated one in the way compounds are absorbed or
evaporated. As humans age, their skin changes texture and appearance. Wrinkles,
elasticity, and moisturization will vary from a teen to an older person (Boireau‐Adamezyk
et al., 2014). A linear regression, performed using a sample group of ages 18-30, 30-40,
40-55, and 55-70, showed that the stratum corneum thickness depended on chronological
aging (Boireau‐Adamezyk et al., 2014). Other contributing factors that influence the
thickness of the skin are related to environmental conditions. In an animal study, it was
found that the SC thickness increases in low humidity (Denda et al., 1998). Likewise,
exposure to higher temperatures results in a thinner SC due to moisture loss through
evaporation (Blank, 1952). As such, dermal absorption can vary from person to person,
especially over different environments.
1.3 Purpose of Study
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An analysis of various aqueous solutions of chemical warfare agents and their associated
dermal absorption rates was conducted using published equations (Frasch & Bunge, 2015).
The work includes large and small dose absorption (Kasting & Miller, 2006). In these
cases, the prediction accuracy depended, in part, on the accuracy of the estimated
parameters. This research aims to build upon the relationships previously discussed. First,
the sensitivity of the parameters will be tested to determine which ones have the most
significant impact on absorption and evaporation rates through the stratum corneum only.
Then, the most sensitive parameters will be used to hypothesize about external factors
contributing to the release mechanism. The kinetics of small and large doses and their
impacts on dermal absorption will be analyzed. Finally, the work will discuss how skin
metabolism and binding influence the transport mechanism.
The thesis examines the external factors influencing the dermal absorption and
evaporation of CWAs. The results will help improve monitoring methods and provide
significant insight into these compounds' complex nature and how they travel through this
biological barrier. In addition, the approach can lead to better risk prevention strategies.
For instance, decontamination is crucial to prevent harmful toxins from spreading to the
body. However, current decontamination procedures may limit the amount of chemicals
that can be effectively removed. Research on pharmacokinetics could potentially prove
instrumental in improving conventional methods or developing new ones.
1.4 Risks from Exposure to Chemical Warfare Agents
Regularly, the human skin is exposed to many chemicals throughout the day. Whether it
be particulates through the air, topical moisturizing lotions, or fibers from clothing, the skin
is vulnerable to foreign exposure. Clothing and lotions are materials that come in contact
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with the skin and may pose low or high risks depending on their characteristics. A lack of
knowledge of how chemicals from these materials are absorbed and diffused through the
dermal layer can be detrimental.
Many people live in an area where the air is clean enough that particle pollution is
not a significant threat. However, individuals are more likely exposed to harmful chemicals
in high-risk areas where they use or transport CWAs. These agents have been deployed for
biological and chemical warfare for a long time. Therefore, researchers studied their
properties as they represent a severe risk to the public. Toxicological data typically list the
entry route and the risk level. For example, lewisite is labeled a vesicating agent because
it causes blisters on exposed skin (Bakshi et al., 2000).
This report will analyze the effects of CWA characteristics on dermal absorption
and evaporation rates. According to relationships published in (Kasting & Miller, 2006),
most CWAs, even those that mostly evaporate, pose a dermal absorption risk because of
their intrinsic properties. Therefore, it is essential to fully understand these features and
their implications to better leverage the information for emergency management or planned
mitigation responses. In addition, the role of environmental conditions on the effects on
kinetics deserves careful consideration.
1.5 Introduction to the Model Parameters
According to (Wartell et al., 1999), meteorological patterns local to the army’s position
were used to predict the movement of the gas clouds in WWI. Even though this method
was largely ineffective, it shows an early understanding of the effects of input parameters
on transdermal absorption. This research explored the direct impact of the diffusion
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coefficient, the ratio κ, and exposure concentration on the skin's absorption rate. The
knowledge of environmental conditions and physicochemical properties can provide
crucial insight into transdermal toxicity. Even though the model can capture the complex
physics and mechanisms of mass transport, its accuracy still relies on users’ specifications.
A lack of understanding of how to estimate the needed parameters and how they affect the
outputs may lead to sub-optimum preventive measures. Such a disconnect could prove to
be lethal.
The diffusion depends primarily on the chemical composition of the chemical
warfare agent itself, as seen in Eq. (34). The molecular weight of the agent contributes to
the diffusion coefficient. A large molecular weight yields a lower diffusion value, thus
increasing the effective time constant of either absorption or evaporation. The composition
of elements in a molecule is the main factor that affects molecular weight. Elements, such
as carbon, hydrogen, nitrogen, and oxygen, impact the molecular weight amount and the
diffusivity through the air. Furthermore, the geometry of the molecule matters as well. For
instance, the presence of a larger ring system can decrease the diffusion through the air. Its
value is directly proportional to the gas-phase mass transfer coefficient.
The ratio κ, defined in Kasting’s work as equation 39 (Kasting & Miller, 2006),
relates the ratio of evaporation to dermal absorption on the gas-phase mass transfer
coefficient, vapor pressure, molecular weight, temperature, permeability coefficient, and
solubility. Like its predecessors, it too directly impacts the finite dose transdermal uptake
of CWAs. The ratio κ is directly proportional to the vapor pressure, the molecular weight,
and the gas-phase mass transfer coefficient. Conversely, κ is inversely proportional to
temperature, solubility, and the permeability coefficient. The heavier a chemical compound
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is the more it tends to evaporate over absorbing into the stratum corneum. The gas-phase
mass transfer coefficient (kg) considers the fluidic properties of the compound and its
relation to the environmental surroundings. Our model is set to a constant indoor air flow
of 16.5 cm/s to simulate exposures of CWAs during shipping or storage. However, the
model would change drastically if the turbulent nature of outside air conditions were to be
instead considered. With higher wind flows, the air directly contributes to evaporating
more product away from the skin. The vapor pressure, which also depends on the
temperature, impacts the ratio κ.
1.6 Small and Large Dose Absorption
The absorption rate across the skin barrier and the transport mechanism are directly related
to the dose size. In addition, the exposure concentration affects the decontamination
efficacy, i.e., the percentage of the initial amount of the compound that can be removed
from the surface (Capoun & Krykorkova, 2019). Therefore, estimating the amount
absorbed when a neutralization protocol is initiated is crucial. To that end, researchers have
developed equations appropriate for large and small dose applications to facilitate an
improved understanding of the effects of CWAs following a topical exposure. Their work
was based on Fick’s second law.
The methods presented in this contribution are applied to CWA’s using the
Wolfram Mathematica environment. Programs will be written to aid researchers study the
effect of physicochemical parameters on the percentages of chemicals absorbed and
evaporated over time. The process time constant will be evaluated in the case of small
doses. Researchers can adapt the tools developed to their analyses and predict the outcome
of dermal exposure scenarios.
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Small-dose absorption assumes that the applied dose is lower than the saturation
amount in the stratum corneum. In addition, the flux at the skin’s surface is proportional to
the local concentration in the skin (Kasting & Miller, 2006). For large doses, the initial
amount is above saturation. However, the rate at which chemicals are removed from the
surface depends on the losses by evaporation and diffusion (2006). Both models apply to
neat, hydrophilic-to-moderately lipophilic liquid coming into contact with the skin (2006).
As such, they can model for a variety of CWAs.
1.7 Metabolism and Binding of CWAs
As toxic molecules penetrate the skin’s surface, the entire body becomes at risk. CWAs
pose a significant threat if the compound has a chance to travel deeper into the skin layers
(i.e., viable epidermis and dermis) (Alkilani et al., 2015). Due to both the mechanistically
connected diffusion and metabolism in the viable tissue, it is essential to thoroughly
understand the behavior of CWA’s penetrating the skin (Boderke et al., 2000). Although
this work assumes negligible skin metabolism and binding, their impact can be significant
in some cases. For example, the dual absorption model has successfully described the
binding permeation of steroids, verapamil, and some amino acids compared to
experimental results with mouse skin (Kydonieus, 2017). Furthermore, animal studies
cannot fully indicate a human’s metabolic effects on the skin due to significant and
unpredictable variations among species (Kydonieus, 2017). So, devising methods to
explain the binding and metabolism through transdermal delivery is strongly encouraged
for future research.
The skin barrier is composed of proteins and a lipid matrix (van Smeden &
Bouwstra, 2016). Nerve agents are toxic because of their ability to inhibit the action of
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certain enzymes (Moshiri et al., 2012). The extent of skin binding depends on the
compound. While metabolism occurs in the viable skin, binding occurs in the stratum
corneum (Tojo, 1987). In-vivo studies use nonlinear saturation kinetic models to predict,
more accurately, the metabolism effect (Boderke et al., 2000). A bioburden relationship
between the binding rate constants, Michaelis-Menten kinetics, and the concentration of
the compound was established by Tojo (1987). The fundamentals of these equations will
be provided to facilitate research on the effects on metabolism and binding in the skin.
1.8 List of CWAs to be Studied
CWAs fall into eight classes: nerve agents, vesicants, blood agents, lung injurants, riotcontrol agents, psychotomimetic agents, toxins, and vomiting agents. This classification is
based on the physiological effects of the CWAs. The following compounds will be selected
for the skin absorption study: VX, sulfur mustard, hydrogen sulfide, phosgene, ethyl
iodoacetate, 3-quinuclidinyl benzilate, colchicine, and adamsite. The dynamic behavior of
other CWAs will be provided in the Appendix.
1.9 Proposed Work
The thesis includes a detailed introduction to CWAs and the development of a
mathematical model to estimate the amount of a chemical compound that can be absorbed
into the skin. The literature review section contains the usage of CWAs, the health risks
they pose, and how the skin is a significant exposure route for these toxic chemicals. In
addition, the compounds used in the study were selected from eight categories. The
methodology was tested on published data. A discussion on small and large dose absorption
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and parameter sensitivity is included. Insights into skin binding and metabolism are
provided based on the absorption and evaporation results.
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CHAPTER 2
THEORY
Previously, a method was developed to study the skin disposition of volatile compounds
(Kasting & Miller, 2006). When a chemical warfare agent’s dose is large, the permeant
forms a saturated concentration at the upper layer of the stratum corneum. Section 2.1
outlines a solution procedure where the process is divided into two stages. One stage
describes the stratum corneum (SC) when the upper tenth of the SC ( f dep ) is saturated with
the CWA and the other stage starts when this upper region is below saturation. The smalldose case is discussed in Section 2.2.
2.1 Large Doses: M 0  M sat
For large doses, the initial amount is greater than the saturated amount. The saturated
amount (Msat ) can be determined by Eq. (25) in (H. F. Frasch, 2012).
Phase 1
Phase 1 describes the point where the pool saturates the stratum corneum’s upper
layer and absorption of the compound into the cell layers. The initial amount on the surface
(Msurf) equals the dose minus the saturated amount:
M surf ( 0 ) = M surf 0 = M 0 − M sat

(1)

Equation (2) represents Fick’s second law of diffusion through the stratum corneum of
thickness hsc :
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Csc
 2Csc
= Dsc
t
z 2

(2)

where CSC is the concentration of the stratum corneum with respect to time (t) and position
(z), Dsc is the diffusion coefficient of the stratum corneum. The initial condition is
represented by

Csc ( z, 0 ) = Csc 0 ( z ) = 0;

f dep hsc  z  hsc

(3)

Csc
z

(4)

The boundary condition at the surface is
dM surf
dt

= −kevap  − Dsc

z = f dep hsc

This mass balance equation involves accumulation and losses due to evaporation and
absorption; kevap is the mass transfer coefficient and ρ as the permeant density.
dM surf
dt

= −kevap  − Dsc

Csc
z

(5)
z = f dep hsc

A perfect sink condition is applied at hsc :

Csc ( hsc , t ) = 0

(6)

Finally, the absorption flux is determined with Fick’s first law represented:

J abs ( t ) = − Dsc

Csc
z

(7)
z = hsc

Therefore, the amount absorbed, the flux due to evaporation and the cumulative amount of
compound evaporated are given by equations (8), (9) and (10), respectively:
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t

M abs ( t ) =  J abs ( )d

(8)

0

J evap ( t ) = kevap 

(9)

Qevap ( t ) = kevap  t

(10)

Phase 2
Phase 2 starts when the pool has evaporated from the surface (i.e. Msurf=0). The
stratum corneum is divided into two regions: an upper (scu) and lower (sc) part. Again,
Equation (11) and (12) apply Fick’s second law of diffusion to both regions:
Cscu
 2Cscu
= Dsc
t
z 2

(11)

Csc
 2Csc
= Dsc
t
z 2

(12)

Equations (13) and (14) are the boundary conditions at z = 0 and z = f dep hsc :
Cscu
z
Cscu
z

=
z =0


hsc

=
z = f dep hsc

Cscu (0, t )

Csc
z

(13)

(14)
z = f dep hsc

The equilibrium partition condition at z = f dep hsc is
Cscu ( f dep hsc , t ) = Csc ( f dep hsc , t )

The perfect sink condition is still valid:
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(15)

Csc ( hsc , t ) = 0

(16)

Cscu ( z , 0 ) = Csat

(17)

Csc ( z , 0 ) = Csc ( t p1 )

(18)

In addition, the initial conditions are

Finally, the amount evaporated and absorbed can be found by:
t

M abs ( t ) =  J abs ( )d

(19)

0

t

M evap ( t ) =  J evap ( )d

(20)

0

And with the fluxes:

J abs ( t ) = − Dsc

J evap ( t ) = Dsc

Csc
z
Cscu
z

(21)
z = hsc

(22)
z =0

The total amount absorbed and evaporated can be found by using the equations for phases
1 and 2.
2.2 Small Dose
A small amount of a compound can also be in direct contact with the skin barrier. Even
though the dose size is below saturation, the absorption can still reach a critical amount
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depending on a number of parameters. The sensitivity of these parameters and their effects
will be studied in more detail in the next section.
Similar to the large dose, the starting point for the mathematical model is with
Fick’s second law of diffusion, represented in equation (23). Fick’s second law is used to
study permeation through skin because it helps predict how the concentration gradient
changes with time through diffusion (Couto et al., 2014).
CSC
 2CSC
= DSC
t
z 2

(23)

where CSC is the chemical concentration in the stratum corneum, t is the time, DSC is the
diffusion through the stratum corneum, and z represents the length. The location where z
equal to zero denotes the position of the skin surface, while the bottom of the stratum
corneum is where z is equal to h (i.e., the layer thickness). Eq. (24) is applied at z=0 and
accounts for the loss through evaporation (H. Frasch, 2012):

Csc
z

=
z =0


Csc (0, t )
h

(24)

where  is the ratio of the steady-state evaporation rate to the steady-state absorption rate.
A perfect skin condition is imposed at z = h :

CSC (h, t ) = 0

(25)

The initial condition is (H. Frasch, 2012)

CSC ( z , 0) = CSC0 ( z ) =
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m0
f dep h
0

{

0  z  f dep h
f dep h  z  h

(26)

The parameters m0 and f dep are the initial finite dermal dose and the fractional
depth through which the CWA is deposited at t = 0 ; fdep is set to 0.1 and h is set at 0.00134
cm (Kasting et al., 2008). Although the system given by Eqs. (23) to (26) can be solved
analytically (H. Frasch, 2012), an orthogonal collocations-based method is employed to
provide a numerical solution to the partial differential equations. The technique converts
the partial differential equations to a system of ordinary differential equations (ODE’s) that
is then solved using Mathematica. The selected approach also facilitates the integration of
multiple skin layers and the effect of skin binding or metabolism into the study.
The cumulative amount of CWA absorbed and evaporated are given by
t

mabs (t ) =  J abs ( )d
0

t

mevap (t ) =  J evap ( )d
0

(27)

(28)

respectively, with the fluxes J abs (t ) and J evap (t ) defined by

J abs (t ) = − DSC

CSC
z

J evap (t ) = DSC

CSC
z

z =h

(29)

z =0

(30)

and

Note that m0 is the sum of the amount of CWA absorbed ( mabs () ) and evaporated (
mevap () ) because binding and metabolism are not addressed in the current framework:
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m0 = mabs () + mevap ()

(31)

It can be shown that the total fractions of CWA absorbed and evaporated are (H. Frasch,
2012):

M abs (  ) =

mabs (  )
m0

=

2 + f dep
2 + 2

(32)

and
M evap (  ) =

mevap (  )
m0

=

2 − f dep
2 + 2

(33)

The initial applied amount m0 is less than the Msat , the mass (per unit area) of chemical
necessary to saturate the top fraction of the stratum corneum (H. Frasch, 2012).
2.3 Parameter Sensitivity
A sensitivity analysis can be studied directly by using Equations (34) to (39), which are
derived from Frasch and Bunge’s calculations (2015). A standard characteristic length is
used for the skin (Frasch & Bunge, 2015). Furthermore, volatile compounds were assumed
to be transported from an aqueous vehicle, through the stratum corneum and to the
bloodstream. The online database, PubChem, was utilized to find most of the parameters
needed (e.g., log(Kow) values).
Eq. (34) represents the effective diffusion coefficient of the stratum corneum in
cm2/s.
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Dsc =

1
h 10−2.80−0.0056 MW
3600

(34)

The diffusion depends on the molecular weight (MW). Eq. (35) is used to calculate
the permeability coefficient kp (Frasch & Bunge, 2015):

k p = 10−2.8+0.66log( Kow )−0.0056 MW

(35)

The parameter kp (cm/h) is essential to the dermal absorption since it is the rate at
which a chemical penetrates the skin. Eq. (36) calculates the sum of key molecular
components of each compound, i.e., the number of carbons, hydrogens, nitrogens, oxygens,
and ring systems:
Sum = 16.5nC + 1.98nH + 5.69nN + 5.48nO − 20.2nring

(36)

The diffusivity (cm2/s) of the compound in the air is given by:
1/2

−3

10  298
D=

(

1.75

1 
 1
 +

 29 MW 

)

1/3 2

Sum1/3 + ( 20.1)

(37)

The gas-phase mass transfer coefficient (cm/h)

k g = 3260 D

2
3

u
L

(38)

is derived by considering the fluid flow characteristics (i.e., Reynolds number) and the
mass transfer properties (i.e., Nusselt number) as explained in (Geankoplis, 2018). The
velocity (u) is set at the indoor condition of 16.5 cm/s. The characteristic length (L) is
assumed to be 13.4 µm (Frasch & Bunge, 2015). The ratio of the steady-state evaporation
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rate to the steady-state absorption rate (κ), described below, combines equations (35) and
(38), the molecular weight and the water solubility parameter (mg/mL):

=

k g Pvap MW
RT

1
k p Sw

(39)

The gas constant is 62.37 mL Torr/K-mmol and the absolute temperature is 298K.
The effective time constants for absorption and evaporation are represented in
equations (40) and (41) which explain the speed at which the compound reaches steady
state.
teff ,abs =
(150 − 60 f dep 2 + 6 f dep 4 ) h 2 + ( 84 + 75 f dep − 80 f dep 2 − 15 f dep 3 + 12 f dep 4 + f dep 5 ) h 2 +

2
3
4
5
2 2
3
5
2 3
1
(14 + 42 f dep − 20 f dep − 20 f dep + 6 f dep + 2 f dep ) h  + ( 7 f dep − 5 f dep + f dep ) h 
30 Dsc (12 − 4 f dep 2 ) + (16 + 6 f dep − 8 f dep 2 − f dep 3 )  + ( 4 + 8 f dep − 4 f dep 2 − 2 f dep 3 )  2 + ( 2 f dep − f dep 3 )  3

(40)

and

teff ,evap =
( 48 + 24 f dep − 8 f dep 2 − 4 f dep 3 + f dep 4 ) h 2 + ( 8 + 28 f dep − 6 f dep 2 − 8 f dep 3 + 2 f dep 4 ) h 2 +

2
3
4
2 2
1 
( 4 f dep + 2 f dep − 4 f dep + f dep ) h 
30 Dsc
( 4 + 2 f dep − f dep 2 ) + ( 4 + 4 f dep − 2 fdep 2 )  + ( 2 f dep − f dep 2 )  2

(41)

A parameter sensitivity study was conducted using the mathematical models for
small and large doses. The following parameters were investigated because of their effects
on the rate of absorption and evaporation: κ, D, and m0 . Mathematica was used to find a
randomized set of points around nominal values of κ, D, and m0 . 10% around the mean
value was used to generate the resulting profiles.
2.4 Binding and Metabolism
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The effects of the diffusion coefficient binding and metabolism through the layer of the
skin were studied with the relationships defined by Tojo in a bilayer (SC and viable) skin
permeation model (Tojo, 1987).
{1 +

{1 +

pa
C
C
M a Ca

} a = ( Da a ) −
2
(1 + qa Ca ) t
x
x
Ba + Ca

pb
C
C
M a Ca
M bCb

} b = ( Db b ) +
−
2
(1 + qbCb ) t
x
x
Ba + Ca (1 + Ca ) B + C
b
b
Ki

{1 +

pc
C
C
M bCb

} c = ( Dc c ) +
2
C
(1 + qcCc ) t
x
x
(1 + a ) Bb + Cb
Ki

(42)

(43)

(44)

Equations (42) through (44) are based on the Langmuir isotherm, which is a simple type
of adsorption equilibrium model that relates the area covered by the adsorbate molecules
on the surface of solid adsorbents as a function of partial pressure or concentration at a
fixed temperature (Ye et al., 2021). Drug A is converted into Drug B and Drug C, which
can either be an active or nonactive metabolite, for transdermal metabolism (Tojo, 1987).
Where Ki is the inhibition constant of the second reaction for Drug A; Bb & Ba are the
Michaelis-Menten kinetics parameters for Drug B and A, respectively; C is the drug
concentration in the skin, and ρ and q are the binding rate constants based on dual
absorption model (Tojo, 1987). These mass balances over differential skin volume are
applied to the SC without metabolism (0≤x≤h) and to the viable skin without drug binding
(h<x≤H, and ρ=q=0) (Tojo, 1987). The equations (42) through (44) can be simplified to
equations (45) through (47) at a low concentration of Drug A.
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pa
C
C

} a = ( Da a ) − k1Ca
2
(1 + qa Ca ) t x
x

(45)

pb
C
C

} b = ( Db b ) + k1Ca − k2Cb
2
(1 + qbCb ) t
x
x

(46)

pc
C
C

} c = ( Dc c ) + k2Cb
2
(1 + qcCc ) t x
x

(47)

{1 +
{1 +

{1 +

where k is the rate constant of enzymatic reaction in viable skin (Tojo, 1987).
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CHAPTER 3
METHODS
Mathematica was utilized to simulate the mathematical models of the small and large
doses. Two different codes were created, one that applies to large quantities while the other
considers small amounts. A collocation method converted the partial differential equations
(PDEs) into ordinary partial differential equations (ODEs). Then, the simulations yielded
absorption and evaporation profiles based on the ratio κ. Other key model parameters were
the stratum corneum thickness, the fractional depth and the dose size. The algorithm also
helped conduct a parameter sensitivity analysis. The program generated random κ,
and

DSC

M 0 values corresponding to a deviation of 10% around the mean value. Equations (39)

were applied to determine how the effects of parameter uncertainty on the calculation of κ.
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CHAPTER 4
RESULTS AND DISCUSSION
4.1 Effects of Model Parameters on the Cumulative Amount of CWA Absorbed
and Evaporated
A study was conducted to assess the effects of the model parameters on process dynamics
for a small dose application. As referenced in Eq. (39), the ratio κ is the ratio of the steadystate evaporation rate to the steady-state absorption rate, i.e., a crucial property in
determining the fate of the CWA. Therefore, it was chosen to be one of the inputs to vary.
The diffusion coefficient was the next important property. Its value can significantly
contribute to accelerating the amount of chemicals absorbed into the body or the
evaporation from the skin barrier for compounds that have a higher tendency to evaporate
from the skin’s surface. Finally, the investigation also considered the dose's influence on
the skin’s surface M0. Even below Msat, a large or small dose can modify the ability of a
CWA to diffuse through the skin or evaporate.
CWAs can travel through the environment when released. It is pertinent to
understand the significance of parameter changes because they can drastically affect
transdermal transport and tissue concentrations. One of the causes of a larger κ could be a
small temperature. Different surroundings (particularly outdoors) can lower or increase its
value. For instance, if the climate is more tropical, a lower κ is expected. The analysis of
the effects of the diffusion coefficient and κ have been conducted for both small- and largedose concentration models. The results are summarized in Figures 4.1.1-4.1.12 for the
small dose model and Figures 4.1.13-4.1.24 for the large dose model. VX, adamsite, and
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colchicine were used as reference compounds. Similar studies were pursued for the
remaining CWA’s (See the Appendix).
Small Dose:

Mabs

Figure 4.1.1 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using VX as a reference compound.

Mevap

Figure 4.1.2 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using VX as a reference compound.
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Mabs

Figure 4.1.3 Graphical representation of the effect of the ratio κ for the absorption profile
using VX as a reference compound.

Mevap

Figure 4.1.4 Graphical representation of the effect of the ratio κ for the evaporation profile
using VX as a reference compound.
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Mabs

Figure 4.1.5 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using adamsite as a reference compound.

Mevap

Figure 4.1.6 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using adamsite as a reference compound.
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Mabs

Figure 4.1.7 Graphical representation of the effect of the ratio κ for the absorption profile
using adamsite as a reference compound.

Mevap

Figure 4.1.8 Graphical representation of the effect of the ratio κ for the evaporation profile
using adamsite as a reference compound.

28

Mabs

Figure 4.1.9 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using colchicine as a reference compound.

Mevap

Figure 4.1.10 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using colchicine as a reference compound.
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Mabs

Figure 4.1.11 Graphical representation of the effect of the ratio κ for the absorption profile
using colchicine as a reference compound.

Mevap

Figure 4.1.12 Graphical representation of the effect of the ratio κ for the evaporation
profile using colchicine as a reference compound.

Large Dose:
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Mabs

Figure 4.1.13 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using VX as a reference compound.

Mevap

Figure 4.1.14 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using VX as a reference compound.
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Mabs

Figure 4.1.15 Graphical representation of the effect of the ratio κ for the absorption profile
using VX as a reference compound.

Mevap

Figure 4.1.16 Graphical representation of the effect of the ratio κ for the evaporation
profile using VX as a reference compound.
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Mabs

Figure 4.1.17 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using adamsite as a reference compound.

Mevap

Figure 4.1.18 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using adamsite as a reference compound.
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Mabs

Figure 4.1.19 Graphical representation of the effect of the ratio κ for the absorption profile
using adamsite as a reference compound.

Mevap

Figure 4.1.20 Graphical representation of the effect of the ratio κ for the evaporation
profile using adamsite as a reference compound.
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Mabs

Figure 4.1.21 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using colchicine as a reference compound.

Mevap

Figure 4.1.22 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using colchicine as a reference compound.
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Mabs

Figure 4.1.23 Graphical representation of the effect of the ratio κ for the absorption profile
using colchicine as a reference compound.

Mevap

Figure 4.1.24 Graphical representation of the effect of the ratio κ for the evaporation
profile using colchicine as a reference compound.

The parameters for κ and diffusion were varied with κ and Dsc being the values found from
the analysis of the charts in the appendix. The absorption profiles of small and large doses
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did not vary significantly with a change in the ratio κ. The outlier was VX in the large dose
model, in which the differences were appreciable enough to see that a higher the ratio κ
resulted in a lower absorption. Comparably, the ratio κ did significantly affect the
evaporation of the compounds. It was determined that a larger κ typically resulted in a
larger evaporation. For both large and small doses, an increase in diffusion coefficient has
led to an increase in the cumulative amount evaporated and absorbed. It was seen that of
the two parameters, the diffusion coefficient was the more significant in impact. This is
because a larger diffusion coefficient increases the speed at which it reaches steady state.
From this analysis, it can be seen that if one is concerned with the severity of CWAs being
absorbed through the skin, the diffusion coefficient has a far greater effect.
4.2 Sensitivity Analysis
A representation of the parameters’ magnitude is tabularized below. Using 10% around the
mean value, the randomly collected points for the adamsite are displayed in Table 4.2.1.
Table 4.2.1 Data Points for κ, Dsc, and M0
κ [10−7 ]

Dsc [10−11 ]

M0

1.269

1.832

0.009047

1.486

1.900

0.01082

1.236

1.808

0.009992

1.328

1.585

0.01007

0.9553

1.537

0.01042

1.216

1.629

0.01066

1.049

1.418

0.008940
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1.450

1.291

0.01070

1.208

1.699

0.01039

1.388

1.859

0.01071

The cumulative amount absorbed and evaporated were plotted using the values listed in
Table 4.2.1. Figure 4.2.25 and Figure 4.2.26 show the results for adamsite.
Mabs

Figure 4.2.25 Effects of random changes on the cumulative amount of adamsite absorbed
– small doses.
Mevap

Figure 4.2.26 Effects of random changes on the cumulative amount of adamsite evaporated
– small doses.
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Figure 4.2.27 Effects of random changes on the cumulative amount of VX absorbed –
small doses.

Mevap

Figure 4.2.28 Effects of random changes on the cumulative amount of VX evaporated –
small doses.
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Figure 4.2.29 Effects of random changes on the cumulative amount of colchicine absorbed
– small doses.

Mevap

Figure 4.2.30 Effects of random changes on the cumulative amount of colchicine
evaporated – small doses.
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Mabs

Figure 4.2.31 Effects of random changes on the cumulative amount of adamsite absorbed
– large doses.
Mevap

Figure 4.2.32 Effects of random changes on the cumulative amount of adamsite
evaporated – large doses.
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Mabs

Figure 4.2.33 Effects of random changes on the cumulative amount of VX absorbed –
large doses.
Mevap

Figure 4.2.34 Effects of random changes on the cumulative amount of VX evaporated –
large doses.
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Mabs

Figure 4.2.35 Effects of random changes on the cumulative amount of colchicine
absorbed – large doses.
Mevap

Figure 4.2.36 Effects of random changes on the cumulative amount of colchicine
evaporated – large doses.
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As shown with the techniques presented in our computational model, the parameter
sensitivity of the values for κ, the diffusion coefficient, and the initial dose were assessed
for their effects on the absorption or evaporation curves presented. The compounds studied
were relative to their respected CWA classifications as to serve as representation for each
unique type. With 10% around the mean value, the computational model is able to create a
new set of random diffusion, κ, and initial dose values to compare how much the amount
absorbed or evaporated could deviate as a result of the parameter uncertainty. VX,
adamsite, and colchicine compounds were selected based upon their similar favorability to
absorb into the skin. Figures 4.2.25-4.2.30 represent the “small dose model” where the
initial dose was less than the saturated value. Figures 4.2.31-4.2.36 represent the “large
dose model” where the initial dose was larger than the saturated value. Uncertainties in the
parameters influence the absorption and evaporation profiles and, consequently, the
exposure assessment. Due to the substantial change in the cumulative amount absorbed,
the severity in side effects from exposure could prove to be deadly. In light of these results,
toxicity studies and ensuing measures to prevent the spread of the CWAs into the organs
and tissues should consider the implications of the parameter estimations.
4.3 Toxicity
From the analysis in 4.2., VX, colchicine, and adamsite have a proclivity to absorb into the
skin. We can conclude that a significant risk is imposed on the skin barrier if coming into
contact with these three compounds. Consulting Occupational Exposure Limits (OELs),
taken in regard to inhalation, provide a baseline to compare the modeling data to toxicity
levels in humans. The compounds' toxicity was accessed using the relationship to convert
OELs to exposure dose as a dermal exposure benchmark (Keil, 2009). The daily Total
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Weight Average permissible (TWA) value for the compound VX is 0.000003 mg/m3
(Council, 2003). For males with an average ventilation of 17.22 m3/day, the exposure dose
should not exceed 5.17×10-5 mg/day. Likewise, for females with an average ventilation of
13.59 m3/day, the exposure dose should not exceed 4.08×10-5 mg/day. The average hand
areas of males and females are 448 and 392 cm2, respectively (Lee et al., 2007). If only the
hand is exposed while the rest of the body is protected, it can be assumed that the amount
absorbed per time and area for males is 4.80×10-6 µg×cm-2× hr-1 and for females 4.33×106

µg×cm-2×hr-1.
Figure 4.3.37 represents the plot of the flux of the compound VX with a

concentration below saturation. The value used for the initial dose was 68 µg×cm-2, which
is the maximum amount without exceeding the saturated point. As seen, the toxicity is not
reached, and can be assumed to not be lethal up to this concentration amount.

Figure 4.3.37 Flux graph of VX for small amount.
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Figure 4.3.38 A representation of the OEL for VX at an initial concentration greater than
saturation.
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Figure 4.3.39 A representation of the effective time constants for absorption (blue) and
evaporation (orange) for the compounds colchicine, adamsite, and VX.
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However, as seen in Figure 4.3.38, for an initial concentration larger than the saturation,
the OEL for both sexes are exceeded at about 3 minutes at a flux of about 6.91×10-5 µg×cm2

× hr-1. The flux was simulated with a 10% increase of Msat for the initial concentration

which resulted in 0.761 mg/cm2. The cumulative amount absorbed at this time period was
about 1.73×10-6 mg/cm2. Figure A.100 in the Appendix shows the graphical representation
of this amount. It can be assumed that the risk of VX lethality would increase with a larger
concentration and the window of time to react and decontaminate the affected skin would
decrease. Figure 4.3.39 shows the effective time constants for both absorption and
evaporation for the three compounds. VX’s molecular weight, vapor pressure, logKow, and
water solubility had contributed to causing the lowest effective time constants.
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CHAPTER 5
CONCLUSION
Two computational models from Frasch and Kasting were developed and simulated in the
Wolfram Mathematica environment. Small and large concentrations were analyzed for the
transdermal permeability of CWAs. A large ratio of κ favored the evaporation of CWAs.
A rise in the diffusion coefficient increased the absorption and evaporation of CWAs from
the skin. Parameter uncertainty can have an appreciable impact on the dynamic profiles
and the development of protocols to reduce the risk of contamination. The procedure
outlined can be combined with occupational exposure limit data for inhalation to better
understand toxicity due to dermal absorption.
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APPENDIX
CWA Tables with Captions:
Table A.1 Nerve Agents with Parameter Values Estimated by the Procedure Outlined in
the Text
Dsc
kp
MW
Compound [g/mol] LogKow [cm/hr]

Pvap
[torr]

Sarin

140.09

0.3 4.11x10

-4

2.86

Soman

182.17

1.78 2.26x10-3

Tabun

162.13
267.37

2.09 1.21x10

180.16

1.67 1.96x10-3

GV
159.27
O,Odiisopropyl
fluorophosph
ate
184.15

-0.78 6.21x10-5

1.13 8.21x10

-4

0.580

1.7 6.51x10

-4

-4

VX
Cyclosarin,
GF

Amiton

269.34

2

[cm /s]

Sw
kg
[mg/mL] [cm/hr]

-11

κ

10

Csat
M sat
M 0 teffabs teffevap
3
2
2
Ksc [mg/cm ] [µg/cm ] [µg/cm ] [hr] [hr] M abs∞ M evap∞

46.38 875.85 991.25

9.69 5.32

246.64

33.05

29.74 0.600 0.377 0.0510

0.949

0.410

21.00 583.04

49.31

5.63 13.7

288.42

38.65

34.78

1.07 0.689 0.0689

0.931

0.38 3.49x10-4

0.0700

98.00 625.64

11.17

7.29 5.58

546.68

73.26

65.93 0.935 0.659 0.128

0.872

-3

-4

30.00 500.17

0.170

1.88 17.2

516.24

69.18

62.26

9.34 0.862

0.138

0.0440

3.70 587.72

34.48

5.78 12.7

47.06

6.31

0.0682

1000 554.96

5.22

8.78x10

4.48x10

9.81

5.68

1.06 0.691 0.0768

0.923

7.57 2.87 2866.41

384.1 345.69

1.04 0.802 0.203

0.797

15.40 600.06 272.60

5.49 8.88

136.73

18.32

1.07 0.670 0.0535

0.947

65.92 509.72 0.0800

1.83 12.99

855.98

114.7 103.23 10.70 10.24 0.930 0.0704

16.49

Table A.2 Vesicants with Parameter Values Estimated by the Procedure Outlined in the
Text
Dsc
MW
Compound [g/mol] LogKow
Sulfur
Mustard,
HD
159.08
2.14
Lewisite
207.32
2.56
HN-3
204.53
2.27
HN-1
170.08
2.02
HN-2
156.05
0.91
Phosgene
oxime
113.93
0.73
Ethyldichloro
arsine
174.89
2.34
Methyldichlo
roarsine
160.86
1.85
Phenyldichlo
roarsine
222.93
3.1

kp
Pvap
Sw
kg
[cm/hr] [torr] [mg/mL] [cm/hr]

0.00527
0.00535
0.00357
0.00381
0.00085

0.110 0.609
0.395 0.500
0.0110 0.160
0.250 0.160
0.170 121.40

[cm2/s]
10-11

κ

707.92 208.00
859.30 1415
616.46 131.00
618.84 2320
652.66 9.08

Csat
M sat
M 0 teffabs teffevap
Ksc [mg/cm3] [µg/cm2] [µg/cm2] [hr] [hr] M abs∞ M evap∞

7.58
4.07
4.22
6.58
7.89

17.9
25
19.8
16.3
7.72

10.88
1.46
1.31 0.773 0.487 0.0545 0.945
12.51
1.68
1.51 1.43 0.896 0.0507 0.896
3.16
0.42
0.38 1.40 0.882 0.0572 0.943
2.61
0.35
0.32 0.883 0.554 0.0504 0.950
937.3 89.1651 113.04 0.892 0.643 0.144 0.856

0.00111

11.2

25.00 935.52

2320

13.6

6.9

172.56

23.12

20.81 0.427 0.268 0.0504 0.950

0.00582

2.29

0.588 834.42

5260

6.19 20.9

12.27

1.64

1.48 0.938 0.589 0.0502 0.950

0.00331 0.0544

1.80 977.74

77.40

7.41 14.4

25.92

3.47

3.13 0.804 0.511 0.0621 0.938

0.00994 0.0330 0.0804 682.09 338.00

3.33 41.2

3.31

0.44
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0.4

1.75

1.10 0.0528 0.947

Table A.3 Blood Agents with Parameter Values Estimated by the Procedure Outlined in
the Text
Dsc
kp
MW
Compound [g/mol] LogKow [cm/hr]
HCN
Cyanogen
chloride
Hydrogen
sulfide

Pvap
Sw
kg
[torr] [mg/mL] [cm/hr]

[cm2/s]

Csat
M sat
M0
teffabs teffevap
Ksc [mg/cm3] [µg/cm2] [µg/cm2] [hr]
[hr] M abs∞ M evap∞

-11

κ

10

95.40 1159.91 1.71x104

41.6 3.86

367.97

49.31

44.38 0.140

0.088 0.0501 0.950

1230 0.0275 1126.27 4.14x108

26.7 3.58

0.100

0.1

0.012 0.217

0.136 0.0500 0.950

3.98 1591.82 7.95x107

38.0 2.08

8.29

1.11

27.025

-0.25 0.000765

742

61.46

-0.38 0.000403

34.08

-1.38 0.000125 13600

1.00 0.153 0.0958 0.0500 0.950

Table A.4 Lung Injurants with Parameter Values Estimated by the Procedure Outlined in
the Text
Dsc
kp
MW
Compound [g/mol] LogKow [cm/hr]

Pvap
[torr]

Sw
kg
[mg/mL] [cm/hr]

[cm2/s]
-11

κ

10

Csat
M sat
M 0 teffabs teffevap
Ksc [mg/cm3] [µg/cm2] [µg/cm2] [hr] [hr] M abs∞ M evap∞

-0.71 0.000150

1420 475.10 1012.71 1.07x105

197.8

1.49 0.00119

10.0

2.39

4

824.75 3.09x10

4.6 11.3

26.87

3.60

3.24

1.26 0.792 0.0500

0.950

Chlorine
70.9
Perfluoroisobu
tene
200.03

0.85 0.00231

5830

6.30 2678.97 4.09x106

23.6 7.44

46.85

6.28

5.65 0.246 0.154 0.0500

0.950

3.03

1740

7

4.47 38.4

4.34

0.48

0.52

0.950

Phosgene
Diphosgene

98.91

0.0120

0.113

16.5 2.98 1415.24 189.64 170.68 0.352 0.221 0.0500

742.19 1.03x10

1.30 0.815 0.0500

0.950

Table A.5 Riot-control Agents with Parameter Values Estimated by the Procedure
Outlined in the Text
Dsc
kp
MW
Compound [g/mol] LogKow [cm/hr]
Chloropicrin
Bromobenzyl
cyanide
1Chloroaceto
phenone
2chlorobenzili
dene
malononitrile
Xylyl
bromide
Bromoaceto
ne
Ethyl
iodoacetate

Pvap
[torr]

Sw
kg
[mg/mL] [cm/hr]

-11

κ

10

Csat
M sat
M 0 teffabs teffevap
3
2
2
Ksc [mg/cm ] [µg/cm ] [µg/cm ] [hr] [hr] M abs∞ M evap∞

4

7.08 17.2

27.88

3.74

3.36 0.820 0.514 0.0500

0.950

0.678 616.29

56.30

4.71 14.2

9.65

1.29

1.16

1.28 0.817 0.0666

0.933

0.00540

1.81 682.04

4.18

8.04 15.3

27.6

3.7

3.33

1.03 0.821 0.233

0.767

-5

0.119 573.73

0.180

5.18 29.8

3.55

0.48

0.43

3.54 3.365 0.855

0.145

0.153 0.0611 617.51 576.00

5.43 58.6

3.58

0.48

0.43

1.07 0.674 0.0516

0.948

4

10.1 4.75

330.9

44.34

39.91 0.575 0.361 0.0500

0.950

2790

3.74 12.3

18.71

2.51

164.37

2.09 0.00456

24.0

196.04

1.83 0.00204

0.0120

154.59

1.93 0.00406

188.61

2.76 0.00923 3.40x10

185.06

3.43

136.98

0.11 0.00032

90.0

214

1.62 0.00118

0.640

0.0268

[cm2/s]

1.62 891.62 2.56x10

69.63 759.78 2.26x10
1.52 678.73

50

2.26

1.55 0.975 0.0503

0.950

Table A.6 Psychomimetic Agents with Parameter Values Estimated by the Procedure
Outlined in the Text
Dsc
Csat
M sat
M 0 teffabs teffevap
[cm2/s]
kp
Pvap
Sw
kg
MW
3
2
-11
Compound [g/mol] LogKow [cm/hr] [torr] [mg/mL] [cm/hr]
Ksc [mg/cm ] [ug/cm ] [ug/cm2] [hr] [hr] M abs∞ M evap∞
κ
10
3quinuclidinyl
benzilate
337.4
3.01 0.00198 2.38x10-10
0.2 437.17 4.76x10-6 0.761 37.7
7.54
1.01
0.91 27.3 26.2 1.00 4.52x10-6

Table A.7 Toxins with Parameter Values Estimated by the Procedure Outlined in the
Text
Dsc
MW
Compound [g/mol] LogKow
Colchicine

399.4

kp
[cm/hr]

Pvap
[torr]

[cm2/s]

Sw
kg
[mg/mL] [cm/hr]

1.03 4.40x10-5 3.20x10-11

-11

κ

10

0.24 429.26 2.80x10-5

Csat
M sat
M 0 teffabs teffevap
Ksc [mg/cm3] [µg/cm2] [µg/cm2] [hr] [hr] M abs∞ M evap∞

0.342 8.33

2.00

0.27

0.240 60.7

58.4 1.002.70x10-5

Table A.8 Vomiting Agents with Parameter Values Estimated by the Procedure Outlined
in the Text
Dsc
kp
MW
Compound [g/mol] LogKow [cm/hr]
Trifluoronitro
somethane 99.012
1.06 0.00221

Pvap
[torr]

Sw
kg
[mg/mL] [cm/hr]

[cm2/s]
-11

κ

10

Csat

M sat

M0

teffabs teffevap
2
Ksc [mg/cm ] [µg/cm ] [µg/cm ] [hr] [hr] M abs∞
3

2

14.58 960.45 1.18x106

16.5

8.49

123.78

16.59

14.93 0.352

Adamsite
277.58
4.05 0.0208 2.00x10-13 0.00065 570.77 1.26x10-7
Diphenylchlo
-5
-4
4
roarsine
264.58 0.00045 5.23x10 4.50x10 0.00272 555.28 2.50x10
Diphenylcya
-6
noarsine
255.15
3.29 0.00876 7.16x10 0.01882 536.55
0.320

1.65

127

0.0800 0.0110

0.0100 12.6

1.95

4.46

0.0121 0.0016 1.46x10

7460

Effects of Model Parameters for Small Dose:
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2.2 50.22

-3

0.9500 0.1300

2.98

0.1100 7.68

0.221 0.0500
12.1

M evap∞
0.950

1.000 1.20x10-7

1.87 0.0500

0.950

7.25

0.230

0.770

Mabs

Figure A.40 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using 3-quinuclidinyl benzilate as a reference compound.

Mevap

Figure A.41 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using 3-quinuclidinyl benzilate as a reference compound.
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Figure A.42 Graphical representation of the effect of the ratio κ for the absorption profile
using 3-quinuclidinyl benzilate as a reference compound.

Mevap

Figure A.43 Graphical representation of the effect of the ratio κ for the evaporation
profile using 3-quinuclidinyl benzilate as a reference compound.
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Figure A.44 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using ethyl iodoacetate as a reference compound.

Mevap

Figure A.45 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using ethyl iodoacetate as a reference compound.
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Mabs

Figure A.46 Graphical representation of the effect of the ratio κ for the absorption profile
using ethyl iodoacetate as a reference compound.

Mevap

Figure A.47 Graphical representation of the effect of the ratio κ for the evaporation
profile using ethyl iodoacetate as a reference compound.
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Figure A.48 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using hydrogen sulfide as a reference compound.

Figure A.49 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using hydrogen sulfide as a reference compound.
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Figure A.50 Graphical representation of the effect of the ratio κ for the absorption profile
using hydrogen sulfide as a reference compound.

Figure A.51 Graphical representation of the effect of the ratio κ for the evaporation
profile using hydrogen sulfide as a reference compound.
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Figure A.52 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using phosgene as a reference compound.

Figure A.53 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using phosgene as a reference compound.
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Figure A.54 Graphical representation of the effect of the ratio κ for the absorption profile
using phosgene as a reference compound.

Figure A.55 Graphical representation of the effect of the ratio κ for the evaporation
profile using phosgene as a reference compound.
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Figure A.56 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using sulfur mustard as a reference compound.

Figure A.57 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using sulfur mustard as a reference compound.
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Figure A.58 Graphical representation of the effect of the ratio κ for the absorption profile
using sulfur mustard as a reference compound.

Figure A.59 Graphical representation of the effect of the ratio κ for the evaporation
profile using sulfur mustard as a reference compound.
Effects of Model Parameters Large Dose:
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Figure A.60 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using 3-quinuclidinyl benzilate as a reference compound.

Figure A.61 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using 3-quinuclidinyl benzilate as a reference compound.
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Figure A.62 Graphical representation of the effect of the ratio κ for the absorption profile
using 3-quinuclidinyl benzilate as a reference compound.

Figure A.63 Graphical representation of the effect of the ratio κ for the evaporation
profile using 3-quinuclidinyl benzilate as a reference compound.
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Figure A.64 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using ethyl iodoacetate as a reference compound.

Figure A.65 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using ethyl iodoacetate as a reference compound.
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Figure A.66 Graphical representation of the effect of the ratio κ for the absorption profile
using ethyl iodoacetate as a reference compound.

Figure A.67 Graphical representation of the effect of the ratio κ for the evaporation
profile using ethyl iodoacetate as a reference compound.

65

Figure A.68 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using hydrogen sulfide as a reference compound.

Figure A.69 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using hydrogen sulfide as a reference compound.
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Figure A.70 Graphical representation of the effect of the ratio κ for the absorption profile
using hydrogen sulfide as a reference compound.

Figure A.71 Graphical representation of the effect of the ratio κ for the evaporation
profile using hydrogen sulfide as a reference compound.
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Figure A.72 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using phosgene as a reference compound.

Figure A.73 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using phosgene as a reference compound.
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Figure A.74 Graphical representation of the effect of the ratio κ for the absorption profile
using phosgene as a reference compound.

Figure A.75 Graphical representation of the effect of the ratio κ for the evaporation
profile using phosgene as a reference compound.
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Figure A.76 Graphical representation of the effect of the diffusion coefficient for the
absorption profile using sulfur mustard as a reference compound.

Figure A.77 Graphical representation of the effect of the diffusion coefficient for the
evaporation profile using sulfur mustard as a reference compound.
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Figure A.78 Graphical representation of the effect of the ratio κ for the absorption profile
using sulfur mustard as a reference compound.

Figure A.79 Graphical representation of the effect of the ratio κ for the evaporation
profile using sulfur mustard as a reference compound.
Small Dose Parameter Sensitivity:
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Mabs

Figure A.80 Effects of random changes on the cumulative amount of 3-quinuclidinyl
benzilate absorbed – small doses.

Mevap

Figure A.81 Effects of random changes on the cumulative amount of 3-quinuclidinyl
benzilate evaporated – small doses.
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Figure A.82 Effects of random changes on the cumulative amount of ethyl iodoacetate
absorbed – small doses.

Mevap

Figure A.83 Effects of random changes on the cumulative amount of ethyl iodoacetate
evaporated–small doses.
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Figure A.84 Effects of random changes on the cumulative amount of hydrogen sulfide
absorbed–small doses.

Mevap

Figure A.85 Effects of random changes on the cumulative amount of hydrogen sulfide
evaporated–small doses.
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Mabs

Figure A.86 Effects of random changes on the cumulative amount of phosgene
absorbed–small doses.

Mevap

Figure A.87 Effects of random changes on the cumulative amount of phosgene
evaporated–small doses.
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Figure A.88 Effects of random changes on the cumulative amount of sulfur mustard
absorbed–small doses.

Mevap

Figure A.89 Effects of random changes on the cumulative amount of sulfur mustard
evaporated–small doses.
Large Dose Parameter Sensitivity:
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Figure A.90 Effects of random changes on the cumulative amount of 3-quinuclidinyl
benzilate absorbed – large doses.

Mevap

Figure A.91 Effects of random changes on the cumulative amount of 3-quinuclidinyl
benzilate evaporated – large doses.
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Mabs

Figure A.92 Effects of random changes on the cumulative amount of ethyl iodoacetate
absorbed – large doses.

Mevap

Figure A.93 Effects of random changes on the cumulative amount of ethyl iodoacetate
evaporated – large doses.
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Mabs

Figure A.94 Effects of random changes on the cumulative amount of hydrogen sulfide
absorbed – large doses.

Mevap

Figure A.95 Effects of random changes on the cumulative amount of hydrogen sulfide
evaporated – large doses.
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Mabs

Figure A.96 Effects of random changes on the cumulative amount of phosgene absorbed
– large doses.

Figure A.97 Effects of random changes on the cumulative amount of phosgene
evaporated – large doses.
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Mabs

Figure A.98 Effects of random changes on the cumulative amount of sulfur mustard
absorbed – large doses.

Mevap

Figure A.99 Effects of random changes on the cumulative amount of sulfur mustard
evaporated – large doses.
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mabs

Figure A.100 The cumulative amount of VX absorbed when the dermal OEL limit has
been exceeded.

82

REFERENCES
Alkilani, A. Z., McCrudden, M. T. C., & Donnelly, R. F. (2015). Transdermal Drug
Delivery: Innovative Pharmaceutical Developments Based on
Disruption of the Barrier Properties of the stratum corneum.
Pharmaceutics, 7(4), 438-470.
https://doi.org/10.3390/pharmaceutics7040438
Andrews, S. N., Jeong, E., & Prausnitz, M. R. (2013). Transdermal delivery of
molecules is limited by full epidermis, not just stratum corneum.
Pharmaceutical research, 30(4), 1099-1109.
https://doi.org/10.1007/s11095-012-0946-7
Bakshi, K. S., Pang, S. N., & Snyder, R. (2000). Review of the US Army's health
risk assessments for oral exposure to six chemical-warfare agents.
Review of the US Army's health risk assessments for oral exposure to
six chemical-warfare agents., 59(5/6).
Black, R. (2016). Development, historical use and properties of chemical warfare
agents.
Blank, I. H. (1952). Factors Which Influence the Water Content of the Stratum
Corneum. Journal of Investigative Dermatology, 18(6), 433-440.
https://doi.org/https://doi.org/10.1038/jid.1952.52
Boderke, P., Schittkowski, K., Wolf, M., & Merkle, H. P. (2000). Modeling of
diffusion and concurrent metabolism in cutaneous tissue. Journal of
Theoretical Biology, 204(3), 393-407.
Boireau‐Adamezyk, E., Baillet‐Guffroy, A., & Stamatas, G. (2014). Age‐
dependent changes in stratum corneum barrier function. Skin
Research and Technology, 20(4), 409-415.
Cao, Y., Elmahdy, A., Zhu, H., Hui, X., & Maibach, H. I. (2020). Binding Affinity
and Decontamination of Dermal Decontamination Gel (DDGel) to
Model Chemical Warfare Agent (CWA) Simulants. In Skin
Decontamination (pp. 163-181). Springer.
Capoun, T., & Krykorkova, J. (2019). Study of Decomposition of Chemical
Warfare Agents using Solid Decontamination Substances. Toxics,
7(4), 63. https://doi.org/10.3390/toxics7040063
Chauhan, S., D’cruz, R., Faruqi, S., Singh, K., Varma, S., Singh, M., & Karthik, V.
(2008). Chemical warfare agents. Environmental Toxicology and
Pharmacology, 26(2), 113-122.
Colchicine. (2015). https://static.cymitquimica.com/products/45/pdf/sds1146006.pdf
Coleman, K. (2005). Historical Precedents? In A History of Chemical Warfare (pp.
1-10). Springer.
Council, N. R. (2003). Acute Exposure Guideline Levels for Selected Airborne
Chemicals: Volume 3.
Couto, A., Fernandes, R., Cordeiro, M. N. S., Reis, S. S., Ribeiro, R. T., & Pessoa,
A. M. (2014). Dermic diffusion and stratum corneum: a state of the
art review of mathematical models. Journal of Controlled Release,
177, 74-83.
83

Dancik, Y., Miller Ma Fau - Jaworska, J., Jaworska J Fau - Kasting, G. B., &
Kasting, G. B. Design and performance of a spreadsheet-based
model for estimating bioavailability of chemicals from dermal
exposure. (1872-8294 (Electronic)).
Denda, M., Sato, J., Masuda, Y., Tsuchiya, T., Koyama, J., Kuramoto, M., Elias, P.
M., & Feingold, K. R. (1998). Exposure to a Dry Environment
Enhances Epidermal Permeability Barrier Function. Journal of
Investigative Dermatology, 111(5), 858-863.
https://doi.org/https://doi.org/10.1046/j.1523-1747.1998.00333.x
Frasch, H. (2012). Dermal absorption of finite doses of volatile compounds.
Journal of pharmaceutical sciences, 101 7, 2616-2619.
Frasch, H. F. (2012). Dermal absorption of finite doses of volatile compounds.
Journal of pharmaceutical sciences, 101(7), 2616-2619.
Frasch, H. F., & Bunge, A. L. (2015). The transient dermal exposure II: postexposure absorption and evaporation of volatile compounds. Journal
of pharmaceutical sciences, 104(4), 1499-1507.
Freemantle, M. (2015). The Chemists' War: 1914-1918. Royal Society of
Chemistry.
Ganesan, K., Raza, S., & Vijayaraghavan, R. (2010). Chemical warfare agents.
Journal of pharmacy and bioallied sciences, 2(3), 166.
Ganesan, K., Raza, S. K., & Vijayaraghavan, R. (2010). Chemical warfare agents.
J Pharm Bioallied Sci, 2(3), 166-178. https://doi.org/10.4103/09757406.68498
Geankoplis, C. J. (2018). Transport processes and separation process principles
(Fifth edition. ed.). Prentice Hall.
Gorzelanny, C., Mess, C., Schneider, S. W., Huck, V., & Brandner, J. M. (2020).
Skin barriers in dermal drug delivery: Which barriers have to be
overcome and how can we measure them? Pharmaceutics, 12(7),
684.
Goswami, D. G., Agarwal, R., & Tewari-Singh, N. (2018). Phosgene oxime:
Injury and associated mechanisms compared to vesicating agents
sulfur mustard and lewisite. Toxicol Lett, 293, 112-119.
https://doi.org/10.1016/j.toxlet.2017.11.011
Hilmas, E., & Hilmas, C. J. (2009). CHAPTER 61 - Medical Management of
Chemical Toxicity in Pediatrics. In R. C. Gupta (Ed.), Handbook of
Toxicology of Chemical Warfare Agents (pp. 919-950). Academic
Press. https://doi.org/https://doi.org/10.1016/B978-0123744845.00061-4
Janik, E., Ceremuga, M., Saluk-Bijak, J., & Bijak, M. (2019). Biological Toxins
as the Potential Tools for Bioterrorism. International journal of
molecular sciences, 20(5), 1181.
https://doi.org/10.3390/ijms20051181
Kasting, G. B., & Miller, M. A. (2006). Kinetics of finite dose absorption through
skin 2: volatile compounds. Journal of pharmaceutical sciences,
95(2), 268-280.

84

Kasting, G. B., Miller, M. A., & Bhatt, V. D. (2008). A spreadsheet-based method
for estimating the skin disposition of volatile compounds:
application to N,N-diethyl-m-toluamide (DEET). J Occup Environ
Hyg, 5(10), 633-644. https://doi.org/10.1080/15459620802304245
Keil, C. B. C. C. E. A. T. R. e. (2009). Mathematical models for estimating
occupational exposure to chemicals.
Kydonieus, A. F. (2017). Treatise on controlled drug delivery: fundamentalsoptimization-applications. CRC Press.
Lee, J. Y., Choi Jw Fau - Kim, H., & Kim, H. (2007). Determination of hand
surface area by sex and body shape using alginate. (1880-6791
(Print)).
Moshiri, M., Darchini-Maragheh, E., & Balali-Mood, M. (2012). Advances in
toxicology and medical treatment of chemical warfare nerve agents.
Daru : journal of Faculty of Pharmacy, Tehran University of
Medical Sciences, 20(1), 81-81. https://doi.org/10.1186/2008-223120-81
Mueller, A. (2017). Biomimetic Nanotechnology. De Gruyter.
Tojo, K. (1987). Mathematical modeling of transdermal drug delivery. Journal of
chemical engineering of Japan, 20(3), 300-308.
van Smeden, J., & Bouwstra, J. A. (2016). Stratum Corneum Lipids: Their Role
for the Skin Barrier Function in Healthy Subjects and Atopic
Dermatitis Patients. Curr Probl Dermatol, 49, 8-26.
https://doi.org/10.1159/000441540
Wartell, M. A., Kleinman, M. T., Huey, B. M., & Duffy, L. M. (1999). Strategies
to protect the health of deployed US forces: force protection and
decontamination.
Wexler, P., & Anderson, B. D. (2005). Encyclopedia of toxicology (2nd ed.).
Elsevier. Book review (E-STREAMS) http://www.estreams.com/es0911/es0911_4525.html
Publisher description
http://www.loc.gov/catdir/enhancements/fy0726/2005920934-d.html
Wexler, P., & Anderson, B. D. (2014). Encyclopedia of toxicology (Third edition.
ed.). Elsevier/AP, Academic Press is an imprint of Elsevier.
Ye, W., Pan, Y., He, L., Chen, B., Liu, J., Gao, J., Wang, Y., & Yang, Y. (2021).
Chapter 3 - Design with modeling techniques. In H. D. Goodfellow
& Y. Wang (Eds.), Industrial Ventilation Design Guidebook
(Second Edition) (pp. 109-183). Academic Press.
https://doi.org/https://doi.org/10.1016/B978-0-12-816673-4.000080

85

